Press "Enter" to skip to content

New patent expiration for AGILE drug TWIRLA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for AGILE drug TWIRLA

Annual Drug Patent Expirations for TWIRLA
Annual Drug Patent Expirations for TWIRLA

Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this drug.

This drug has fifty-six patent family members in twenty-three countries.

The generic ingredient in TWIRLA is ethinyl estradiol; levonorgestrel. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for AGILE drug TWIRLA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!